Skip to main content
. 2014 Jun 24;4(2):43–56. doi: 10.5500/wjt.v4.i2.43

Table 3.

Suggested approach to donor-transmitted Mycobacterium tuberculosis

Deceased donors
1TB Risk 2Suggestive radiology 3Donor testing 4Donor treated Accept allograft Additional consent 5Recipient treatment Additional recipient testing
Low No Negative N/A Yes None None None
Low Yes Negative No/Yes Yes Yes Chemoprophylaxis None
Low Yes Pending No/Yes No N/A N/A N/A
Elevated No Negative No/Yes Yes Yes Chemoprophylaxis None
Elevated Yes Negative No/Yes Yes Yes Chemoprophylaxis None
Elevated Yes Pending No/Yes No N/A N/A N/A
Elevated Yes Positive No/Yes No N/A N/A N/A
Prior active TB Yes Negative Yes Yes Yes Chemoprophylaxis None
Prior active TB Yes Pending Yes Yes Yes Chemoprophylaxis None
Prior active TB Yes Positive No/Yes No N/A N/A N/A
Prior active TB Yes Positive No No N/A N/A N/A
Active TB Yes Positive No/Yes No N/A N/A N/A
Living donors
Low No Negative N/A Yes No None None
LTBI No Positive Yes No Yes None None
Active TB No Positive No No N/A N/A N/A
Elevated Yes Negative No/Yes Yes Yes Chemoprophylaxis None
1

Based on history and physical examination;

2

Apical fibrosis and/or pleural thickening on chest radiograph or computerized tomography scan;

3

Sputum acid fast bacilli (AFB) smear and culture; molecular testing on smear-positive sputum;

4

Must be documented treatment with appropriate anti-TB therapy;

5

Refers to accepted regimen for treatment of latent tuberculosis infection (LTBI). TB: Tuberculosis; N/A: Not applicable.